Announcement of Meeting of the Secretary's Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020, 61689-61690 [E9-28320]
Download as PDF
Federal Register / Vol. 74, No. 226 / Wednesday, November 25, 2009 / Notices
Part 515, effective on the corresponding
date shown below:
License Number: 018630N.
Name: American International
Shipping Company.
Address: 7 Emily Road, Manalapan,
NJ 07726.
Date Revoked: November 7, 2009.
Reason: Failed to maintain a valid
bond.
License Number: 014160N.
Name: Cargo Logistics Inc.
Address: 186 Sherman Ave., P.O. Box
186, Glenridge, NJ 07028.
Date Revoked: October 21, 2009.
Reason: Failed to maintain a valid
bond.
License Number: 004411N.
Name: Debbie D. Sukhai-Sheffield
DBA S & S Enterprises.
Address: 4463 Niobe Circle, Rancho
Cordova, CA 95742.
Date Revoked: October 30, 2009.
Reason: Failed to maintain a valid
bond.
Reason: Failed to maintain a valid
bond.
License Number: 020146N.
Name: Global Carrier Alliance Corp.
Address: 1880 Century Park East, Ste.
900, Los Angeles, CA 90067.
Date Revoked: October 28, 2009.
Reason: Failed to maintain a valid
bond.
Sandra L. Kusumoto,
Director, Bureau of Certification and
Licensing.
[FR Doc. E9–28265 Filed 11–24–09; 8:45 am]
License Number: 018084F.
Name: Go-Trans (North America) Inc.
Address: 147–32 Farmers Blvd., 2nd
Floor, Jamaica, NY 11434.
Date Revoked: August 22, 2009.
Reason: Failed to maintain a valid
bond.
License Number: 019788N.
Name: Miriam Family Cargo, Inc.
Address: 18 NW 12th Ave., Miami, FL
33128.
Date Revoked: October 22, 2009.
License No.
020295NF ..........
Yavid Corporation, 10913 NW. 30th Street, #103, Doral, FL
33172.
BILLING CODE 6730–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Meeting of the
Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2020
AGENCY: Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science,
Office of Disease Prevention and Health
Promotion.
ACTION: Notice of meeting.
sroberts on DSKD5P82C1PROD with NOTICES
BILLING CODE 6730–01–P
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary
License; Reissuance
Notice is hereby given that the
following Ocean Transportation
Intermediary license has been reissued
by the Federal Maritime Commission
pursuant to section 19 of the Shipping
Act of 1984 (46 U.S.C. Chapter 409) and
the regulations of the Commission
pertaining to the licensing of Ocean
Transportation Intermediaries, 46 CFR
Part 515.
Name/address
Sandra L. Kusumoto,
Director, Bureau of Certification and
Licensing.
[FR Doc. E9–28264 Filed 11–24–09; 8:45 am]
Authority: 42 U.S.C. 217a, Section 222
of the Public Health Service Act, as
amended. The Committee is governed
by the provision of Public Law 92–463,
as amended (5 U.S.C. Appendix 2),
which sets forth standards for the
formation and use of advisory
committees.
SUMMARY: The U.S. Department of
Health and Human Services (HHS)
announces the next federal advisory
committee meeting regarding the
national health promotion and disease
prevention objectives for 2020. This
meeting will be open to the public and
will be held online via WebEx software.
VerDate Nov<24>2008
17:36 Nov 24, 2009
Jkt 220001
61689
Date reissued
September 17, 2009.
The Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2020 will
address efforts to develop the nation’s
health promotion and disease
prevention objectives and strategies to
improve the health status and reduce
health risks for Americans by the year
2020. The Committee will provide to the
Secretary of Health and Human Services
advice and consultation for developing
and implementing the next iteration of
national health promotion and disease
prevention goals and objectives and
provide recommendations for initiatives
to occur during the initial
implementation phase of the goals and
objectives. HHS will use the
recommendations to inform the
development of the national health
promotion and disease prevention
objectives for 2020 and the process for
implementing the objectives. The intent
is to develop and launch objectives
designed to improve the health status
and reduce health risks for Americans
by the year 2020.
DATES: The Committee will meet on
December 11, 2009 from 1:30 p.m. to
4:30 p.m. Eastern Standard Time (EST).
ADDRESSES: The meeting will be held
online, via WebEx software. For detailed
instructions about how to make sure
that your windows computer and
browser is set up for WebEx, please visit
the ‘‘Secretary’s Advisory Committee’’
Web page of the Healthy People Web
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
site at: https://www.healthypeople.gov/
hp2020/advisory/default.asp.
FOR FURTHER INFORMATION CONTACT:
Emmeline Ochiai, Designated Federal
Officer, Secretary’s Advisory Committee
on National Health Promotion and
Disease Prevention Objectives for 2020,
U.S. Department of Health and Human
Services, Office of Public Health and
Science, Office of Disease Prevention
and Health Promotion, 1101 Wootton
Parkway, Room LL–100, Rockville, MD
20852, (240) 453–8259 (telephone),
(240) 453–8281 (fax). Additional
information is available on the Internet
at https://www.healthypeople.gov.
SUPPLEMENTARY INFORMATION:
Purpose of Meeting: Every 10 years,
through the Healthy People initiative,
HHS leverages scientific insights and
lessons from the past decade, along with
the new knowledge of current data,
trends, and innovations to develop the
next iteration of national health
promotion and disease prevention
objectives. Healthy People provides
science-based, 10-year national
objectives for promoting health and
preventing disease. Since 1979, Healthy
People has set and monitored national
health objectives to meet a broad range
of health needs, encourage
collaborations across sectors, guide
individuals toward making informed
health decisions, and measure the
impact of our prevention and health
promotion activities. Healthy People
E:\FR\FM\25NON1.SGM
25NON1
61690
Federal Register / Vol. 74, No. 226 / Wednesday, November 25, 2009 / Notices
2020 will reflect assessments of major
risks to health and wellness, changing
public health priorities, and emerging
issues related to our nation’s health
preparedness and prevention.
Public Participation at Meeting:
Members of the public are invited to
listen to the online Committee meeting.
There will be no opportunity for oral
public comments during the online
Committee meeting. Written comments,
however, are welcome throughout the
development process of the national
health promotion and disease
prevention objectives for 2020. They can
be submitted through the Healthy
People Web site at: https://
www.healthypeople.gov/hp2020/
comments/ or they can be e-mailed to
HP2020@hhs.gov.
To listen to the Committee meeting,
individuals must pre-register to attend
at the Healthy People Web site located
at https://www.healthypeople.gov.
Participation in the meeting is limited.
Registrations will be accepted until
maximum WebEx capacity is reached
and must be completed by 9 a.m. EST
on December 11, 2009. A waiting list
will be maintained should registrations
exceed WebEx capacity. Individuals on
the waiting list will be contacted as
additional space for the meeting
becomes available.
Registration questions may be
directed to Hilary Scherer at
HP2020@norc.org (e-mail), (301) 634–
9374 (phone) or (301) 634–9301 (fax).
Dated: November 18, 2009.
Penelope Slade-Sawyer,
RADM, USPHS, Deputy Assistant Secretary
for Health (Disease Prevention and Health
Promotion).
[FR Doc. E9–28320 Filed 11–24–09; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
sroberts on DSKD5P82C1PROD with NOTICES
AGENCY: Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Spreading Techniques to Radically
Reduce Antibiotic Resistant Bacteria
VerDate Nov<24>2008
17:36 Nov 24, 2009
Jkt 220001
(Methicillin Resistant Staphylococcus
aureus, or MRSA).’’ In accordance with
the Paperwork Reduction Act, 44 U.S.C.
350 1–3520, AHRQ invites the public to
comment on this proposed information
collection.
DATES: Comments on this notice must be
received by January 25, 2010.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Spreading Techniques To Radically
Reduce Antibiotic Resistant Bacteria
(Methicillin Resistant Staphylococcus
aureus, or MRSA)
Healthcare Acquired Infections (HAIs)
caused almost 100,000 deaths among
the 2.1 million people who acquired
infections while hospitalized in 2000,
and HAI rates have risen relentlessly
since then. Alarmingly, 70% of HATs
are due to bacteria that are resistant to
commonly used antibiotics, with
Methicillin Resistant Staphylococcus
aureus (MRSA) being the most rapidly
growing, and among the most virulent,
pathogens. Resistance is increasing
rapidly in all types of hospitals (Huang
2007). Despite evidence that routinely
applied, simple interventions do work,
most hospitals have failed to make
notable progress in reducing MRSA
infections. Hospitals in some European
countries and select U.S. hospitals,
however, have succeeded with
impressive results.
Sites that have already achieved
dramatic decreases in their MRSA
infection rates have done so by
implementing precautions to prevent
transmission, using system redesign
approaches. Further, many hospitals
have successfully instituted isolation
procedures for patients suspected to be
MRSA carriers. In doing so, these
hospitals have followed the broadly
disseminated guidelines for hand
hygiene and contact isolation
precautions. This study is a follow up
to a recent study implemented in 6
hospital systems in the Indianapolis
metropolitan area that used a ‘‘MRSA
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
intervention bundle’’ composed of
active surveillance screening, contact
isolation precautions, and increased
hand hygiene. Preliminary data from
that initial study suggest a 60% decrease
in MRSA rates in participating intensive
care units (ICUs) (Doebbeling, B.
Redesigning Hospital Care for Quality
and Efficiency Applications of Positive
Deviance and Lean in Reducing MRSA.
Presentation at AHRQ Annual Meeting,
Rockville, MD, Sept 2009).
This study is designed to further test
this intervention bundle in non-ICU
settings in hospitals currently using the
intervention bundle in their ICUs, as
well as in additional ICUs in newly
recruited hospital systems. This project
will utilize the same guidelines and
precautions that were applied in the
original study, and will add an
innovative feature that will use
electronic medical record systems to
improve identifying, communicating
and tracking MRSA infections among
healthcare systems. More specifically,
this study has five aims:
(1) Further test the ‘‘MRSA
intervention bundle’’ from the original
Indianapolis MRSA study, and test the
intervention in additional units in the 4
original Indianapolis hospital systems
and an additional 3 hospital systems
beyond Indianapolis;
(2) Identify and monitor healthcare
associated community onset (HACO)
MRSA cases and controls who receive
care in participating hospitals and
affiliated settings, identify strategies to
reduce HACO MRSA and demonstrate
reduction of HACO MRSA;
(3) Assess the relative effectiveness of
various antibiotics in abatement or
eradication of MRSA carriage in
hospital patients;
(4) Evaluate the effectiveness of the
tested implementation strategies and
innovations by applying information
technology to enable consistent
collection, sharing, analysis and
reporting of data;
(5) Disseminate findings and promote
outreach to target audiences and other
stakeholders.
While many secondary data are
available for this study, Aims 1 and 2
involve primary data collection. Use of
the intervention bundle requires that
opinion leaders and front line workers
be equipped with techniques used in
the reorganization of healthcare delivery
to improve health outcomes (Singhal
and Greiner, 2007; IHI, 2005). These
techniques will assist in identifying
goals, implementing the interventions to
meet local needs and measuring and
feeding back progress on key processes
and outcomes to staff and others.
E:\FR\FM\25NON1.SGM
25NON1
Agencies
[Federal Register Volume 74, Number 226 (Wednesday, November 25, 2009)]
[Notices]
[Pages 61689-61690]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-28320]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Meeting of the Secretary's Advisory Committee on
National Health Promotion and Disease Prevention Objectives for 2020
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science, Office of Disease
Prevention and Health Promotion.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 217a, Section 222 of the Public Health Service
Act, as amended. The Committee is governed by the provision of Public
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of advisory committees.
SUMMARY: The U.S. Department of Health and Human Services (HHS)
announces the next federal advisory committee meeting regarding the
national health promotion and disease prevention objectives for 2020.
This meeting will be open to the public and will be held online via
WebEx software. The Secretary's Advisory Committee on National Health
Promotion and Disease Prevention Objectives for 2020 will address
efforts to develop the nation's health promotion and disease prevention
objectives and strategies to improve the health status and reduce
health risks for Americans by the year 2020. The Committee will provide
to the Secretary of Health and Human Services advice and consultation
for developing and implementing the next iteration of national health
promotion and disease prevention goals and objectives and provide
recommendations for initiatives to occur during the initial
implementation phase of the goals and objectives. HHS will use the
recommendations to inform the development of the national health
promotion and disease prevention objectives for 2020 and the process
for implementing the objectives. The intent is to develop and launch
objectives designed to improve the health status and reduce health
risks for Americans by the year 2020.
DATES: The Committee will meet on December 11, 2009 from 1:30 p.m. to
4:30 p.m. Eastern Standard Time (EST).
ADDRESSES: The meeting will be held online, via WebEx software. For
detailed instructions about how to make sure that your windows computer
and browser is set up for WebEx, please visit the ``Secretary's
Advisory Committee'' Web page of the Healthy People Web site at: https://www.healthypeople.gov/hp2020/advisory/default.asp.
FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal
Officer, Secretary's Advisory Committee on National Health Promotion
and Disease Prevention Objectives for 2020, U.S. Department of Health
and Human Services, Office of Public Health and Science, Office of
Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL-
100, Rockville, MD 20852, (240) 453-8259 (telephone), (240) 453-8281
(fax). Additional information is available on the Internet at https://www.healthypeople.gov.
SUPPLEMENTARY INFORMATION:
Purpose of Meeting: Every 10 years, through the Healthy People
initiative, HHS leverages scientific insights and lessons from the past
decade, along with the new knowledge of current data, trends, and
innovations to develop the next iteration of national health promotion
and disease prevention objectives. Healthy People provides science-
based, 10-year national objectives for promoting health and preventing
disease. Since 1979, Healthy People has set and monitored national
health objectives to meet a broad range of health needs, encourage
collaborations across sectors, guide individuals toward making informed
health decisions, and measure the impact of our prevention and health
promotion activities. Healthy People
[[Page 61690]]
2020 will reflect assessments of major risks to health and wellness,
changing public health priorities, and emerging issues related to our
nation's health preparedness and prevention.
Public Participation at Meeting: Members of the public are invited
to listen to the online Committee meeting. There will be no opportunity
for oral public comments during the online Committee meeting. Written
comments, however, are welcome throughout the development process of
the national health promotion and disease prevention objectives for
2020. They can be submitted through the Healthy People Web site at:
https://www.healthypeople.gov/hp2020/comments/ or they can be e-mailed
to HP2020@hhs.gov.
To listen to the Committee meeting, individuals must pre-register
to attend at the Healthy People Web site located at https://www.healthypeople.gov. Participation in the meeting is limited.
Registrations will be accepted until maximum WebEx capacity is reached
and must be completed by 9 a.m. EST on December 11, 2009. A waiting
list will be maintained should registrations exceed WebEx capacity.
Individuals on the waiting list will be contacted as additional space
for the meeting becomes available.
Registration questions may be directed to Hilary Scherer at
HP2020@norc.org (e-mail), (301) 634-9374 (phone) or (301) 634-9301
(fax).
Dated: November 18, 2009.
Penelope Slade-Sawyer,
RADM, USPHS, Deputy Assistant Secretary for Health (Disease Prevention
and Health Promotion).
[FR Doc. E9-28320 Filed 11-24-09; 8:45 am]
BILLING CODE 4150-32-P